We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
(-8.1%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$121M |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$66.8M |
| 3 |
Intuitive Surgical
ISRG
|
+$56.6M |
| 4 |
Welltower
WELL
|
+$48.8M |
| 5 |
Credo Technology Group
CRDO
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$67M |
| 2 |
UnitedHealth
UNH
|
+$44.7M |
| 3 |
Amphenol
APH
|
+$43.9M |
| 4 |
Becton Dickinson
BDX
|
+$36.4M |
| 5 |
Eli Lilly
LLY
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Healthcare | 25.4% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Rivian
RIVN
$23.6B
| – | – |
-78,403
| Closed | -$1.04M |
|
677
Sabra Healthcare REIT
SBRA
$5.56B
| – | – |
-20,268
| Closed | -$351K |
|
678
Skyworks Solutions
SWKS
$9.21B
| – | – |
-9,793
| Closed | -$868K |
|
679
Toronto Dominion Bank
TD
$193B
| – | – |
-362,475
| Closed | -$19.3M |
|
680
Tenet Healthcare
THC
$22.2B
| – | – |
-142,001
| Closed | -$17.9M |
|
681
Textron
TXT
$14.7B
| – | – |
-6,171
| Closed | -$472K |
|
|
WCC
682
WESCO International
WCC
$15.1B
| – | – |
-50,047
| Closed | -$9.06M |
|
683
Workiva
WK
$3.45B
| – | – |
-17,431
| Closed | -$1.91M |
|
684
YPF
YPF
$19.7B
| – | – |
-323,600
| Closed | -$19.6M |
|
685
Zillow
Z
$7.78B
| – | – |
-26,289
| Closed | -$1.95M |
|
|
SNRE
686
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| – | – |
-6,991
| Closed | -$301K |
|
|
ITCI
687
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-214,320
| Closed | -$17.9M |
|
|
ALTR
688
DELISTED
Altair Engineering Inc
ALTR
| – | – |
-614,335
| Closed | -$67M |
|
|
RVNC
689
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-299,039
| Closed | -$909K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2025 Portfolio in Review
As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
- Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
- Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
- Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
- Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
- Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
- Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.
Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.